Home HIV FAQ My Amedeo About Flying Publisher   

Amedeo Prize 2008
The 21 Finalists


  Multiple Sclerosis

  Free Subscription


Articles published in J Neurol Sci

Retrieve available abstracts of 133 articles:
HTML format

Single Articles


    March 2008
  1. YAMOUT B , Barada W, Tohme RA, Mehio-Sibai A, et al
    Clinical characteristics of multiple sclerosis in Lebanon.
    J Neurol Sci. 2008;.
    PubMed     Related articles    Abstract available


  2. GELLEIN K , Skogholt JH, Aaseth J, Thoresen GB, et al
    Trace elements in cerebrospinal fluid and blood from patients with a rare progressive central and peripheral demyelinating disease.
    J Neurol Sci. 2008;266.
    PubMed     Related articles    Abstract available


  3. DELUCA J , Genova HM, Hillary FG, Wylie G, et al
    Neural correlates of cognitive fatigue in multiple sclerosis using functional MRI.
    J Neurol Sci. 2008;.
    PubMed     Related articles    Abstract available


    February 2008
  4. YTTERBERG C , Johansson S, Holmqvist LW, Koch LV, et al
    Longitudinal variations and predictors of increased perceived impact of multiple sclerosis, a two-year study.
    J Neurol Sci. 2008;.
    PubMed     Related articles    Abstract available


  5. TURABELIDZE G , Schootman M, Zhu BP, Malone JL, et al
    Multiple sclerosis prevalence and possible lead exposure.
    J Neurol Sci. 2008;.
    PubMed     Related articles    Abstract available


  6. PALACE J
    Neuroprotection and repair.
    J Neurol Sci. 2008;265.
    PubMed     Related articles    Abstract available


  7. HOMMES OR
    Can we pass from the experimental to the clinical phase in MS stem cell research?
    J Neurol Sci. 2008;265.
    PubMed     Related articles    Abstract available


  8. SCOLDING N , Marks D, Rice C
    Autologous mesenchymal bone marrow stem cells: practical considerations.
    J Neurol Sci. 2008;265.
    PubMed     Related articles    Abstract available


  9. BERGAMASCHI R , Crivelli P, Rezzani C, Patti F, et al
    The DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis.
    J Neurol Sci. 2008;.
    PubMed     Related articles    Abstract available


  10. CASTELLANO V , White LJ
    Serum brain-derived neurotrophic factor response to aerobic exercise in multiple sclerosis.
    J Neurol Sci. 2008;.
    PubMed     Related articles   


    January 2008
  11. HOUFF S , Berger JR
    Reply to "'Thinking without thinking' about natalizumab and PML".
    J Neurol Sci. 2008;264.
    PubMed     Related articles   


  12. EGGERT M , Goertsches R, Seeck U, Dilk S, et al
    Changes in the activation level of NF-kappa B in lymphocytes of MS patients during glucocorticoid pulse therapy.
    J Neurol Sci. 2008;264.
    PubMed     Related articles    Abstract available


    December 2007
  13. ARIAS M , Constela IR, Iglesias S, Arias-Rivas S, et al
    The autoscopic phenomena in neurological clinic: a study of two cases.
    J Neurol Sci. 2007;263.
    PubMed     Related articles    Abstract available


  14. LAU KK , Wong WW, Sheng B, Yu IT, et al
    The clinical course of multiple sclerosis patients in Hong Kong.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  15. GRAZIOLI E , Zivadinov R, Weinstock-Guttman B, Lincoff N, et al
    Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


    November 2007
  16. MOTL RW , Snook EM
    Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12).
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  17. POSER CM
    The environment and the nervous system.
    J Neurol Sci. 2007;262.
    PubMed     Related articles    Abstract available


    October 2007
  18. DENNEY DR , Lynch SG, Parmenter BA
    A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: Speed matters.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  19. GALIMBERTI D , Scalabrini D, Fenoglio C, De Riz M, et al
    Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  20. NAIT-OUMESMAR B , Picard-Riera N, Kerninon C, Baron-Van Evercooren A, et al
    The role of SVZ-derived neural precursors in demyelinating diseases: From animal models to multiple sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  21. MATSUOKA T , Matsushita T, Osoegawa M, Ochi H, et al
    Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging findings.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  22. COMI G
    Is it clinically relevant to repair focal multiple sclerosis lesions?
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  23. ZIVADINOV R , Zorzon M, De Masi R, Nasuelli D, et al
    Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  24. DJURIC T , Zivkovic M, Stankovic A, Dincic E, et al
    Association of the MMP-3 5A/6A gene polymorphism with multiple sclerosis in patients from Serbia.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


    September 2007
  25. DE STEFANO N , Filippi M, Hawkins C
    Short-term combination of glatiramer acetate with IV steroid treatment preceding treatment with GA alone assessed by MRI-disease activity in patients with relapsing-remitting multiple sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  26. VILLAR LM , Garcia-Barragan N, Sadaba MC, Espino M, et al
    Accuracy of CSF and MRI criteria for dissemination in space in the diagnosis of multiple sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  27. BANNERMAN PG , Hahn A
    Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
    J Neurol Sci. 2007;260.
    PubMed     Related articles    Abstract available


  28. ZIPOLI V , Portaccio E, Hakiki B, Siracusa G, et al
    Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: An open-label comparative study of efficacy and safety.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  29. MANNA I , Liguori M, Valentino P, Condino F, et al
    Preliminary evidences of a NOS2A protective effect from Relapsing-Remitting Multiple Sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


    August 2007
  30. VAS A , Shchukin Y, Karrenbauer VD, Cselenyi Z, et al
    Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: Preliminary comparative PET studies with [(11)C]vinpocetine and [(11)C]PK11195 in patients.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  31. GAY F
    Bacterial toxins and Multiple Sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  32. PLUCHINO S , Martino G
    The therapeutic plasticity of neural stem/precursor cells in multiple sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  33. FREEDMAN MS
    Bone marrow transplantation: does it stop MS progression?
    J Neurol Sci. 2007;259.
    PubMed     Related articles    Abstract available


  34. FAZEKAS F , Strasser-Fuchs S, Hommes OR
    Intravenous immunoglobulin in MS: promise or failure?
    J Neurol Sci. 2007;259.
    PubMed     Related articles    Abstract available


  35. MILLER A , Panitch H
    Therapeutic use of dextromethorphan: key learnings from treatment of pseudobulbar affect.
    J Neurol Sci. 2007;259.
    PubMed     Related articles    Abstract available


  36. MONTALBAN X
    MS treatment: postmarketing studies.
    J Neurol Sci. 2007;259.
    PubMed     Related articles    Abstract available


  37. OGER J
    Immunosuppression: promises and failures.
    J Neurol Sci. 2007;259.
    PubMed     Related articles    Abstract available


  38. CLERICO M , Barbero P, Contessa G, Ferrero C, et al
    Adherence to interferon-beta treatment and results of therapy switching.
    J Neurol Sci. 2007;259.
    PubMed     Related articles    Abstract available


  39. ARNOLD DL
    The place of MRI in monitoring the individual MS patient.
    J Neurol Sci. 2007;259.
    PubMed     Related articles    Abstract available


  40. SORENSEN PS
    The gap between effect of drugs and effectiveness of treatments.
    J Neurol Sci. 2007;259.
    PubMed     Related articles    Abstract available


  41. OGER J
    HTLV-1 infection and the viral etiology of multiple sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


    July 2007
  42. TEDESCHI G , Dinacci D, Lavorgna L, Prinster A, et al
    Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  43. UBEDA JV
    Comparative features of the epidemiology of multiple sclerosis and Parkinson's disease: Environmental factors of potential etiological importance.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  44. SOTELO J
    On the viral hypothesis of multiple sclerosis: Participation of varicella-zoster virus.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  45. SERGOTT RC , Frohman E, Glanzman R, Al-Sabbagh A, et al
    The role of optical coherence tomography in multiple sclerosis: Expert panel consensus.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  46. CABRE P
    Migration and multiple sclerosis: The French West Indies experience.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  47. FILIPPI M , Rocca MA
    Toward a definition of structural and functional MRI substrates of fatigue in multiple sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles   


  48. SILANI V , Cova L
    Stem cell transplantation in Multiple Sclerosis: Safety and Ethics.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  49. KARUSSIS D , Kassis I, Basan GS, Slavin S, et al
    Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): A proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


    June 2007
  50. NARAYAN SK , Kumar S, Prabhakar P, Elangovan S, et al
    Multiple Sclerosis in Keralite siblings after migration to the Middle East: A report of familial Multiple Sclerosis from India.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  51. DUNCAN ID
    Replacing cells in multiple sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  52. ZHAO C , Zawadzka M, Roulois AJ, Bruce CC, et al
    Promoting remyelination in multiple sclerosis by endogenous adult neural stem/precursor cells: Defining cellular targets.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


    May 2007
  53. VAKNIN-DEMBINSKY A , Weiner HL
    Relationship of immunologic abnormalities and disease stage in multiple sclerosis: Implications for therapy.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  54. FERNANDEZ O
    Combination therapy in multiple sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


    April 2007
  55. BENCSIK K , Fricska-Nagy Z, Csepany T, Matyas K, et al
    Effects of interrupted immunomodulant therapy on the neurological state of multiple sclerosis patients.
    J Neurol Sci. 2007;.
    PubMed     Related articles   


  56. SINGH MK , Scott TF, Laframboise WA, Hu FZ, et al
    Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  57. HOHLFELD R
    Neurotrophic cross-talk between the nervous and immune systems: Relevance for repair strategies in multiple sclerosis?
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  58. BLAKEMORE WF
    Regeneration and repair in multiple sclerosis: The view of experimental pathology.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available



  59. European Charcot Foundation Symposium "Treatment Strategies in Multiple Sclerosis. From pathophysiology to clinical practice". 17-19 November 2005 Results from a Round Table Discussion on Rules for individual patient care in MS. J. Palace (c
    J Neurol Sci. 2007;.
    PubMed     Related articles   


  60. SILVA AM , Pereira C, Bettencourt A, Carvalho C, et al
    The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


    March 2007
  61. HEESEN C , Kasper J, Kopke S, Richter T, et al
    Informed shared decision making in multiple sclerosis-inevitable or impossible?
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  62. CHARIL A , Filippi M
    Inflammatory demyelination and neurodegeneration in early multiple sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  63. NEUHAUS O , Kieseier BC, Hartung HP
    Pharmacokinetics and pharmacodynamics of the interferon-betas, glatiramer acetate, and mitoxantrone in multiple sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  64. YONG VW , Zabad RK, Agrawal S, Goncalves Dasilva A, et al
    Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  65. WUERFEL J , Paul F, Zipp F
    Cerebral blood perfusion changes in multiple sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  66. OZAKBAS S , Akdede BB, Kosehasanogullari G, Aksan O, et al
    Difference between generic and multiple sclerosis-specific quality of life instruments regarding the assessment of treatment efficacy.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  67. AMATO MP , Portaccio E
    Clinical outcome measures in multiple sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  68. MCLEOD JG , Barnett MH, Macaskill P, Williams DB, et al
    Long-term prognosis of multiple sclerosis in Australia.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  69. BERGER T , Reindl M
    Multiple sclerosis: Disease biomarkers as indicated by pathophysiology.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  70. LASSMANN H
    Multiple sclerosis: Is there neurodegeneration independent from inflammation?
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  71. MORROW TJ
    The costs and consequences of multiple sclerosis relapses: A managed care perspective.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  72. JOHNSON KP
    Control of multiple sclerosis relapses with immunomodulating agents.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  73. HALPER J
    The psychosocial effect of multiple sclerosis: The impact of relapses.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  74. KALB R
    The emotional and psychological impact of multiple sclerosis relapses.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  75. COYLE PK , Johnson KP
    Relapses matter: the costs & consequences of multiple sclerosis relapses.
    J Neurol Sci. 2007;.
    PubMed     Related articles   


  76. TRABOULSEE A
    MRI relapses have significant pathologic and clinical implications in multiple sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  77. VOLLMER T
    The natural history of relapses in multiple sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  78. ARMUTLU K , Keser I, Korkmaz N, Akbiyik DI, et al
    Psychometric study of Turkish version of Fatigue Impact Scale in multiple sclerosis patients.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  79. LUBLIN FD
    The incomplete nature of multiple sclerosis relapse resolution.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


    February 2007
  80. SCHWID SR , Goodman AD, Weinstein A, McDermott MP, et al
    Cognitive function in relapsing multiple sclerosis: Minimal changes in a 10-year clinical trial.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  81. KOCH M , Mostert J, Heersema D, De Keyser J, et al
    Progression in multiple sclerosis: Further evidence of an age dependent process.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  82. BARAM Y , Miller A
    Auditory feedback control for improvement of gait in patients with Multiple Sclerosis.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


    January 2007
  83. CASSERLY G , Barry T, Tourtellotte WW, Hogan EL, et al
    Absence of Mycoplasma-specific DNA sequence in brain, blood and CSF of patients with multiple sclerosis (MS): A study by PCR and real-time PCR.
    J Neurol Sci. 2007;.
    PubMed     Related articles    Abstract available


  84. SZVETKO AL , Fowdar J, Nelson J, Colson N, et al
    No association between MTHFR A1298C and MTRR A66G polymorphisms, and MS in an Australian cohort.
    J Neurol Sci. 2007;252:49-52.
    PubMed     Related articles    Abstract available


  85. PADUA L , Nociti V, Bartalini S, Patti F, et al
    Reply to "Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients"
    J Neurol Sci. 2007;.
    PubMed     Related articles   


    December 2006
  86. PATTI F , Russo P, Pappalardo A, Macchia F, et al
    Predictors of quality of life among patients with multiple sclerosis: An Italian cross-sectional study.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  87. KOCH M , Mostert J, Heersema D, Teelken A, et al
    Plasma S100beta and NSE levels and progression in multiple sclerosis.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  88. EHRLICH S , Haas J, Zipp F, Infante-Duarte C, et al
    Serum levels of soluble CD95 are not associated with amelioration of multiple sclerosis during pregnancy.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


    November 2006
  89. WARABI Y , Matsumoto Y, Hayashi H
    Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  90. LUND BT , Chakryan Y, Ashikian N, Mnatsakanyan L, et al
    Association of MBP peptides with Hsp70 in normal appearing human white matter.
    J Neurol Sci. 2006;249:122-34.
    PubMed     Related articles    Abstract available


  91. TAJOURI L , Fernandez F, Tajouri S, Detriche G, et al
    Allelic variation investigation of the estrogen receptor within an Australian multiple sclerosis population.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  92. BONNET MC , Deloire MS, Salort E, Dousset V, et al
    Evidence of cognitive compensation associated with educational level in early relapsing-remitting multiple sclerosis.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  93. FRITZSCHING B , Korporal M, Haas J, Krammer PH, et al
    Similar sensitivity of regulatory T cells towards CD95L-mediated apoptosis in patients with multiple sclerosis and healthy individuals.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


    September 2006
  94. JUNG P , Beyerle A, Humpich M, Neumann-Haefelin T, et al
    Ipsilateral silent period: A marker of callosal conduction abnormality in early relapsing-remitting multiple sclerosis?
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


    July 2006
  95. WARABI Y , Yagi K, Hayashi H, Matsumoto Y, et al
    Characterization of the T cell receptor repertoire in the Japanese neuromyelitis optica: T cell activity is up-regulated compared to multiple sclerosis.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  96. FURUYAMA H , Chiba S, Okabayashi T, Yokota SI, et al
    Single nucleotide polymorphisms and functional analysis of MxA promoter region in multiple sclerosis.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


    June 2006
  97. PETERLIN B , Ristiae S, Sepeiae J, Vracko BK, et al
    Region with persistent high frequency of multiple sclerosis in Croatia and Slovenia.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  98. MAGNANO I , Aiello I, Piras MR
    Cognitive impairment and neurophysiological correlates in MS.
    J Neurol Sci. 2006;245.
    PubMed     Related articles    Abstract available


  99. SORENSEN PS , Jonsson A, Mathiesen HK, Blinkenberg M, et al
    The relationship between MRI and PET changes and cognitive disturbances in MS.
    J Neurol Sci. 2006;245.
    PubMed     Related articles    Abstract available


  100. HUIJBREGTS SC , Kalkers NF, de Sonneville LM, de Groot V, et al
    Cognitive impairment and decline in different MS subtypes.
    J Neurol Sci. 2006;245.
    PubMed     Related articles    Abstract available


  101. AMATO MP , Portaccio E, Zipoli V
    Are there protective treatments for cognitive decline in MS?
    J Neurol Sci. 2006;245.
    PubMed     Related articles    Abstract available


  102. ACHIRON A , Barak Y
    Cognitive changes in early MS: a call for a common framework.
    J Neurol Sci. 2006;245.
    PubMed     Related articles    Abstract available


  103. AUDOIN B , Au Duong MV, Malikova I, Confort-Gouny S, et al
    Functional magnetic resonance imaging and cognition at the very early stage of MS.
    J Neurol Sci. 2006;245.
    PubMed     Related articles    Abstract available


  104. LANZILLO R , Prinster A, Scarano V, Liuzzi R, et al
    Neuropsychological assessment, quantitative MRI and ApoE gene polymorphisms in a series of MS patients treated with IFN beta-1b.
    J Neurol Sci. 2006;245.
    PubMed     Related articles    Abstract available


  105. MONTALBAN X , Rio J
    Interferons and cognition.
    J Neurol Sci. 2006;245.
    PubMed     Related articles    Abstract available


  106. HERHOLZ K
    Cognitive dysfunction and emotional-behavioural changes in MS: the potential of positron emission tomography.
    J Neurol Sci. 2006;245.
    PubMed     Related articles    Abstract available


  107. PENNER IK , Kappos L
    Retraining attention in MS.
    J Neurol Sci. 2006;245.
    PubMed     Related articles    Abstract available


    May 2006
  108. RACHBAUER D , Kronbichler M, Ropele S, Enzinger C, et al
    Differences in cerebral activation patterns in idiopathic inflammatory demyelination using the paced visual serial addition task: an fMRI study.
    J Neurol Sci. 2006;244.
    PubMed     Related articles    Abstract available


  109. ANNUNZIATA P , Giorgio A, De Santi L, Zipoli V, et al
    Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta.
    J Neurol Sci. 2006;244.
    PubMed     Related articles    Abstract available


  110. FONTOURA P , Steinman L
    Nogo in multiple sclerosis: Growing roles of a growth inhibitor.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  111. SARTORI E , Edan G
    Assessment of cognitive dysfunction in multiple sclerosis.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  112. YOZBATIRAN N , Baskurt F, Baskurt Z, Ozakbas S, et al
    Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  113. PORCEL J , Montalban X
    Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosis.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  114. MILLER A
    Pseudobulbar affect in multiple sclerosis: Toward the development of innovative therapeutic strategies.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


    April 2006
  115. KUTZELNIGG A , Lassmann H
    Cortical demyelination in multiple sclerosis: A substrate for cognitive deficits?
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  116. JONSSON A , Andresen J, Storr L, Tscherning T, et al
    Cognitive impairment in newly diagnosed multiple sclerosis patients: A 4-year follow-up study.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  117. DERACHE N , Marie RM, Constans JM, Defer GL, et al
    Reduced thalamic and cerebellar rest metabolism in relapsing-remitting multiple sclerosis, a positron emission tomography study: Correlations to lesion load.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  118. AMATO MP , Zipoli V, Portaccio E
    Multiple sclerosis-related cognitive changes: A review of cross-sectional and longitudinal studies.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  119. FEINSTEIN A
    Mood disorders in multiple sclerosis and the effects on cognition.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  120. JONGEN PJ
    Psychiatric onset of multiple sclerosis.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  121. FAZEKAS F , Enzinger C, Ropele S, Schmidt H, et al
    The impact of our genes: Consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  122. PORTACCIO E , Amato MP, Bartolozzi ML, Zipoli V, et al
    Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  123. WATSON GS , Craft S
    Insulin resistance, inflammation, and cognition in Alzheimer's Disease: Lessons for multiple sclerosis.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  124. RANJEVA JP , Audoin B, Au Duong MV, Confort-Gouny S, et al
    Structural and functional surrogates of cognitive impairment at the very early stage of multiple sclerosis.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  125. SCHMIDT R , Enzinger C, Ropele S, Schmidt H, et al
    Subcortical vascular cognitive impairment: Similarities and differences with multiple sclerosis.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  126. MAINERO C , Pantano P, Caramia F, Pozzilli C, et al
    Brain reorganization during attention and memory tasks in multiple sclerosis: Insights from functional MRI studies.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  127. CHRISTODOULOU C , Melville P, Scherl WF, Macallister WS, et al
    Effects of donepezil on memory and cognition in multiple sclerosis.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  128. BENEDICT RH , Zivadinov R
    Predicting neuropsychological abnormalities in multiple sclerosis.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  129. ZAREI M
    Clinical characteristics of cortical multiple sclerosis.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  130. BARAK Y , Achiron A
    Cognitive fatigue in multiple sclerosis: Findings from a two-wave screening project.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  131. ROVARIS M , Comi G, Filippi M
    MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


  132. GAINOTTI G
    Measures of cognitive and emotional changes in multiple sclerosis and underlying models of brain dysfunction.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


    March 2006
  133. MEI FJ , Osoegawa M, Ochi H, Minohara M, et al
    Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.
    J Neurol Sci. 2006;.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


This AMEDEO Service was made possible thanks to the generous unrestricted educational grants provided by Bayer Schering Pharma AG.

Amedeo is a Bernd Sebastian Kamps website.

   Design: